InvestorsHub Logo

Solantey

09/29/13 12:08 PM

#85796 RE: hnbadger1 #85795

Sell off? LOL!!!

It's already the most undervalued stock in the market.

The shorts and the penny flippers tried to take it down on Thursday. They succeeded in transferring a lot of shares from weak hands into strong hands.

This is one press release away from .20 or higher.

I expect the share price to be in the .50 range when AMBS "up-lists" to the NASDAQ or AMEX in the second quarter of 2014.

"Patience is a virtue."

Twitter: @AmarantusBio .... 8,540 followers

Skeetz99

09/29/13 12:23 PM

#85797 RE: hnbadger1 #85795

I would agree that the BD relationship might have headwinds. To me: Gerald has made some recent decisions (like multiple funding announcements) that indicate a BD JV might not be happening anytime soon.

I know Gerald has publicly stated that once the LymPro results are validated; they will get Global interest from other parties. In summary, I believe its a win win situation here; and if Gerald has to do a Partnership down the road (and even with another company); it will be at a much higher price (great news for shareholders).